0.6401
price down icon0.59%   -0.0038
 
loading
Schlusskurs vom Vortag:
$0.6439
Offen:
$0.65
24-Stunden-Volumen:
161.83K
Relative Volume:
0.87
Marktkapitalisierung:
$22.68M
Einnahmen:
$42.62M
Nettoeinkommen (Verlust:
$-8.32M
KGV:
-2.5604
EPS:
-0.25
Netto-Cashflow:
$-15.77M
1W Leistung:
-7.07%
1M Leistung:
+5.28%
6M Leistung:
-26.43%
1J Leistung:
-22.81%
1-Tages-Spanne:
Value
$0.493
$0.689
1-Wochen-Bereich:
Value
$0.493
$0.715
52-Wochen-Spanne:
Value
$0.493
$3.25

Equillium Inc Stock (EQ) Company Profile

Name
Firmenname
Equillium Inc
Name
Telefon
(858) 412-5302
Name
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Name
Mitarbeiter
45
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-08
Name
Neueste SEC-Einreichungen
Name
EQ's Discussions on Twitter

Vergleichen Sie EQ mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EQ
Equillium Inc
0.6401 22.68M 42.62M -8.32M -15.77M -0.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Equillium Inc Stock (EQ) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-10-29 Fortgesetzt Stifel Buy
2021-09-15 Eingeleitet Cantor Fitzgerald Overweight
2020-07-14 Bestätigt H.C. Wainwright Buy
2020-07-10 Fortgesetzt Stifel Buy
2019-02-22 Eingeleitet SVB Leerink Outperform

Equillium Inc Aktie (EQ) Neueste Nachrichten

pulisher
Jan 21, 2025

Equillium stock touches 52-week low at $0.52 amid market challenges - MSN

Jan 21, 2025
pulisher
Jan 15, 2025

Equillium (NASDAQ:EQ) Shares Down 0.9% – What’s Next? - Defense World

Jan 15, 2025
pulisher
Jan 02, 2025

US Penny Stocks To Watch In January 2025 - Simply Wall St

Jan 02, 2025
pulisher
Dec 24, 2024

Equillium (NASDAQ:EQ) Stock Price Down 1.6% – What’s Next? - Defense World

Dec 24, 2024
pulisher
Dec 19, 2024

Equillium stock touches 52-week low at $0.6 amid market challenges - Investing.com Australia

Dec 19, 2024
pulisher
Dec 12, 2024

Equillium Announces Board and Audit Committee Changes - TipRanks

Dec 12, 2024
pulisher
Nov 28, 2024

Contrasting CSL (OTCMKTS:CSLLY) and Equillium (NASDAQ:EQ) - Defense World

Nov 28, 2024
pulisher
Nov 16, 2024

Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge - Simply Wall St

Nov 16, 2024
pulisher
Nov 15, 2024

Equillium CFO Jason Keyes sells $7,000 in stock By Investing.com - Investing.com Nigeria

Nov 15, 2024
pulisher
Nov 15, 2024

Equillium CFO Jason Keyes sells $7,000 in stock - Investing.com

Nov 15, 2024
pulisher
Nov 14, 2024

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates - BioSpace

Nov 14, 2024
pulisher
Nov 13, 2024

Equillium’s Q3 Financials and Clinical Progress in Focus - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Equillium to Present at the Stifel Healthcare Conference - The Bakersfield Californian

Nov 13, 2024
pulisher
Nov 13, 2024

Equillium to Present Clinical Pipeline Updates at Stifel Healthcare Conference | EQ Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer - BioSpace

Nov 13, 2024
pulisher
Nov 09, 2024

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth - MSN

Nov 09, 2024
pulisher
Nov 05, 2024

Equillium keeps equilibrium in GVHD after Ono no-go - BioWorld Online

Nov 05, 2024
pulisher
Nov 02, 2024

Equillium says Ono not acquiring itolizumab, stock craters 36% - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Ono says no to Equillium’s itolizumab - The Pharma Letter

Nov 01, 2024
pulisher
Nov 01, 2024

Jones Trading Downgrades Equillium (EQ) - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Equillium retains rights to itolizumab after Ono's option expires - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Equillium shares downgraded to hold from buy By Investing.com - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Equillium shares downgraded to hold from buy - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Equillium says Ono not acquiring itolizumab, stock craters 36% (NASDAQ:EQ) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

Equillium COO Christine Zedelmayer sells $18,750 in stock - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Equillium COO Christine Zedelmayer sells $18,750 in stock By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 31, 2024

Insider Sale: Sr. Vice President and COO Christine Zedelmayer Se - GuruFocus.com

Oct 31, 2024
pulisher
Oct 22, 2024

Alto Ingredients And 2 Other US Penny Stocks To Watch Closely - Simply Wall St

Oct 22, 2024
pulisher
Oct 19, 2024

Moleculin Biotech (NASDAQ:MBRX) versus Equillium (NASDAQ:EQ) Financial Comparison - Defense World

Oct 19, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Acquires 91,200 Shares of Equillium, Inc. (NASDAQ:EQ) - Defense World

Oct 13, 2024
pulisher
Oct 07, 2024

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer - StockTitan

Oct 07, 2024
pulisher
Sep 27, 2024

Equillium CFO Jason Keyes sells $8,100 in company stock By Investing.com - Investing.com South Africa

Sep 27, 2024
pulisher
Sep 27, 2024

Equillium CFO Jason Keyes sells $8,100 in company stock - Investing.com India

Sep 27, 2024
pulisher
Sep 26, 2024

Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop - Simply Wall St

Sep 26, 2024
pulisher
Sep 22, 2024

Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.

Sep 22, 2024
pulisher
Sep 18, 2024

Equillium executive sells $32,985 in stock - Investing.com India

Sep 18, 2024
pulisher
Sep 17, 2024

Equillium executive sells $32,985 in stock By Investing.com - Investing.com Australia

Sep 17, 2024
pulisher
Sep 17, 2024

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy - Yahoo Finance

Sep 17, 2024

Finanzdaten der Equillium Inc-Aktie (EQ)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Kapitalisierung:     |  Volumen (24h):